Instil Bio Inc (TIL)
25.91
+1.15
(+4.64%)
USD |
NASDAQ |
Nov 22, 16:00
25.91
0.00 (0.00%)
After-Hours: 18:11
Instil Bio Shareholders Equity (Quarterly): 176.33M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 176.33M |
| June 30, 2024 | 195.02M |
| March 31, 2024 | 205.83M |
| December 31, 2023 | 225.83M |
| September 30, 2023 | 234.02M |
| June 30, 2023 | 296.52M |
| March 31, 2023 | 311.15M |
| December 31, 2022 | 363.60M |
| Date | Value |
|---|---|
| September 30, 2022 | 410.59M |
| June 30, 2022 | 458.33M |
| March 31, 2022 | 508.56M |
| December 31, 2021 | 555.20M |
| September 30, 2021 | 601.42M |
| June 30, 2021 | 635.47M |
| March 31, 2021 | 665.15M |
| December 31, 2020 | -39.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-39.60M
Minimum
Dec 2020
665.15M
Maximum
Mar 2021
362.71M
Average
337.38M
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 44.50B |
| Elite Pharmaceuticals Inc | 47.27M |
| BioCardia Inc | 2.753M |
| Zevra Therapeutics Inc | 69.77M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 272.56M |
| Total Liabilities (Quarterly) | 96.23M |